Stanford recently launched the world’s first stem-cell based trial aimed at a devastating skin disease called epidermoloysis bullosa. Physicians from our dermatology team are trying to correct a faulty gene in the skin cells of patients with a severe form of the condition, which causes large, painful wounds and currently has no cure.
